logo
16:03 Jun 25

Hester Biosciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2230.80
-9.10 (-0.41%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hester Biosciences Ltd. Financials

Hester Biosciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2230.80
-9.10 (-0.41%)
16:03 Jun 25
Quality
image/svg+xml

89/100
High Financial Strength

Valuation
image/svg+xml

40/100
Mid Valuation

Technical

66/100
Technically Moderately Bullish

Strength

16

Weakness

0

Opportunity

0

Threats

0

15.44 %

ROE %

8.20 %

ROA %

65.40

EPS

423.46

BVPS

16.72 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
235.01 266.09 304.55 311.1 332.6
Operating Expenses +
175.03 215.48 250.89 250.06 245.95
Raw Material
73.27 82.74 87.13 81.55 86.36
Increase Decrease in Cost
-10.56 -5.25 8.74 6.78 -4.41
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
45.33 56.02 64.13 62.42 62.67
Miscellaneous Expenses
92.23 141.47 156.53 134.51 132.81
Operating Profit
59.98 50.61 53.66 61.04 86.65
Other Income
13.74 15.15 10.64 3.92 9.68
Depreciation
16.58 20.7 17.17 16.8 18.88
Interest
4.06 9.32 19.78 12.7 10.93
Profit before tax and exceptio..
53.08 35.74 27.34 35.47 66.53
Exceptional Items
0 0 0 0 2.94
PBT
53.08 35.74 27.34 35.47 69.46
Provision for Taxation
14.02 12.12 10.79 10.74 18.35
Net Profit
39.06 23.63 16.56 24.73 51.11
NET Profit after MI
39.48 26.63 18.89 27.49 55.64
EPS
46.41 32.96 24.88 33.89 67.57
Operating Profit Margin (%)
25.52 19.02 17.62 19.62 26.05
Net Profit Margin (%)
16.8 10.01 6.2 8.84 16.73

Hester Biosciences Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: